Director Alexander Asam not standing for re-election at 2024 annual meeting

Mineralys Therapeutics, Inc.

Alexander Asam, Ph.D. informed the Board on March 29, 2024 of his decision.
He will not stand for re-election when his term expires at the 2024 annual meeting.
Asam stated the decision was not due to any disagreement with the Company or management.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Alexander Asam

Director

MLYS · Mineralys Therapeutics, Inc.

Filed: April 4, 2024, 7:59 PM ET

On March 29, 2024, Alexander Asam, Ph.D. informed the Board of Directors (the “Board”) of Mineralys Therapeutics, Inc. (the “Company”) of his decision not to stand for re-election to the Board when his current term expires at the Company’s 2024 annual meeting of stockholders.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Alexander Asam departed as Director at Mineralys Therapeutics, Inc..

Action: not stand for re-election
Role: Director

Exact text from the filing

On March 29, 2024, Alexander Asam, Ph.D. informed the Board of Directors (the “Board”) of Mineralys Therapeutics, Inc. (the “Company”) of his decision not to stand for re-election to the Board when his current term expires at the Company’s 2024 annual meeting of stockholders.

View on SEC.gov

Mineralys Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001933414-24-000008

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.